Variants in MCT10 protein do not affect FT3 levels in athyreotic patients.

Silvia Cantara Claudia Ricci Fabio Maino Carlotta MarzocchiF PaciniMaria Grazia Castagna

Published in: Endocrine (2019)

We confirmed the role of DIO2 Thr92Ala polymorphism on T3 levels. On the contrary, SLC16A1 rs17606253 polymorphism did not impair hormone levels in athyreotic patients treated with levothyroxine therapy.

Keyphrases

end stage renal disease
ejection fraction
prognostic factors
stem cells
peritoneal dialysis
gene expression
bone marrow
binding protein
patient reported outcomes
protein protein
cell therapy